Cargando…
PMON120 Clinical Course Of Untreated Giant Invasive Macroprolactinomas- A Case Series
INTRODUCTION: Giant invasive prolactinomas are rare pituitary tumours and have a male preponderance of 9: 1. In majority of cases, dopamine agonists (DA) are the treatment of choice in lowering prolactin and tumour shrinkage. Surgery may be opted in those with acute compressive symptoms or visual lo...
Autores principales: | Aung, Ei Thuzar, Rubab, Umme, Randon, Mark, Gilkes, Catherine, Daousi, Christina, Thondam, Sravan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625803/ http://dx.doi.org/10.1210/jendso/bvac150.1113 |
Ejemplares similares
-
RF01 | PMON77 Low Libido Despite High Testosterone Levels in a Man With FSH-Secreting Pituitary Macroadenoma
por: Khan, Muhammad Ilyas, et al.
Publicado: (2022) -
PMON121 GALACTORRHEA, MACROPROLACTINOMA IN A 53-YEAR-OLD MALE
por: Selman-Geara, Antonio, et al.
Publicado: (2022) -
PMON101 Fluctuating Insulin Requirements in Untreated Acromegaly: From 200-to-0
por: Bellavia, Lauren, et al.
Publicado: (2022) -
A Challenging Case of Pituitary Macroprolactinoma During Pregnancy
por: Zainal, Abir, et al.
Publicado: (2021) -
Macroprolactinoma in a Patient With Schizophrenia: A Therapeutic Challenge
por: Voelz, Eduardo, et al.
Publicado: (2021)